Citations for: Su, Y.; Lian, Q. Q.; Ge, R. S., Contraceptives with novel benefits. Expert Opin Investig Drugs 2012, 21 (1), 83-90.

Entry Type
Name
Value
Parent Entry
Pharmacology Data Field
Antagonist
Medroxy­progesterone Acetate (API)
Pharmacology Data Field
No activity
Nestorone (API)
Pharmacology Data Field
Antagonist
Nestorone (API)
Pharmacology Data Field
Binds to GR but does not show activity in in vivo assays
Nestorone (API)
Pharmacology Data Field
26.8 h
Nestorone (API)
Pharmacology Data Field
Binds to albumin. Does not bind to SHBG.
Nestorone (API)
Pharmacology Data Field
Parenteral. Orally inactive.
Nestorone (API)
Pharmacology Data Field
No activity
Medroxy­progesterone Acetate (API)
Pharmacology Data Field
Binds but no agonist activity. "Weak," "partial" or "moderate" antagonist.
Nomegestrol Acetate (API)
Pharmacology Data Field
Antagonist
Nomegestrol Acetate (API)
Pharmacology Data Field
No activity
Nomegestrol Acetate (API)
Pharmacology Data Field
45-50 h
Nomegestrol Acetate (API)
Pharmacology Data Field
Weak or no agonist and antagonist activity
Dienogest (API)
Pharmacology Data Field
Low to no activity
Dienogest (API)
Pharmacology Data Field
No activity
Dienogest (API)
Pharmacology Data Field
8-10 h
Dienogest (API)
Pharmacology Data Field
90% bound to serum albumin, 10% free. No binding to SHBG or CBG.
Dienogest (API)
Pharmacology Data Field
Partial antagonist (about 30% activity of cyproterone acetate)
Drospirenone (API)
Pharmacology Data Field
No activity
Drospirenone (API)
Pharmacology Data Field
Antagonist (antimineralocorticoid or aldosterone antagonist). Agonist reports vary: "weak" (Africander) to "strong" (Bartsch).
Drospirenone (API)
Pharmacology Data Field
25-33 h
Drospirenone (API)
Pharmacology Data Field
2 h
Dienogest (API)
Pharmacology Data Field
1-2 h
Drospirenone (API)